Business Wire

Accumetrics’ VerifyNow System Receives Health Canada License for Clinical Use

SAN DIEGO--(BUSINESS WIRE)--Accumetrics, Inc., developer of the VerifyNow ® System, the first rapid and easy-to-use system for measuring platelet reactivity to multiple antiplatelet agents, announced ...
TCTMD

Accumetrics Obtains CE Mark for Therapeutic Window Claim on the VerifyNow P2Y12 Test

Accumetrics, Inc., developer of the market-leading VerifyNow® System, announced an expansion in the intended use for the CE marked VerifyNow P2Y12 Test. Physicians can now use the test results to ...
Houston Chronicle

(PZ) Accumetrics Announces Appointment of Steven Frankel as Chief Executive Officer and Director

SAN DIEGO, Oct. 3, 2006 (PRIMEZONE) -- Accumetrics, Inc., a privately held medical device company and maker of the VerifyNow(r) family of diagnostic tests that measure platelet function, today ...
TCTMD

2011 ACCF/AHA Guidelines Incorporate New Recommendation for Platelet Reactivity Testing

SAN DIEGO, Accumetrics, Inc., developer of the VerifyNow® System, the first rapid and easy-to-use point-of-care system for measuring platelet reactivity to multiple antiplatelet agents, announced ...
Fierce Healthcare

Accumetrics Aligned with Medicare’s Hospital Readmissions Reduction Program

Accumetrics Inc., developer of the VerifyNow System, the first rapid and easy-to-use point-of-care system for measuring platelet reactivity to multiple antiplatelet agents, today announced the launch ...